- Home
- TR vs VCYT Comparison
TR vs VCYT Comparison
Compare TR & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TR | VCYT |
|---|---|---|
| Founded | 1896 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.9B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | TR | VCYT |
|---|---|---|
| Price | $37.50 | $39.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $46.00 |
| AVG Volume (30 Days) | 103.4K | ★ 731.6K |
| Earning Date | 02-27-2026 | 02-23-2026 |
| Dividend Yield | ★ 0.96% | N/A |
| EPS Growth | ★ 0.79 | N/A |
| EPS | ★ 1.28 | 0.38 |
| Revenue | ★ $729,620,000.00 | $495,141,000.00 |
| Revenue This Year | N/A | $16.46 |
| Revenue Next Year | N/A | $11.37 |
| P/E Ratio | ★ $29.10 | $106.65 |
| Revenue Growth | 0.34 | ★ 16.41 |
| 52 Week Low | $28.67 | $22.61 |
| 52 Week High | $44.27 | $50.71 |
Technical Indicators
Market Signals| Indicator | TR | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 50.14 | 39.66 |
| Support Level | $37.10 | $40.29 |
| Resistance Level | $38.21 | $45.55 |
| Average True Range (ATR) | 0.86 | 1.92 |
| MACD | 0.09 | -0.28 |
| Stochastic Oscillator | 71.77 | 4.71 |
Price Performance
Historical ComparisonAbout TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.